ATOSBiotechnology / Biotechnology
Atossa Therapeutics Inc
30-Day Price
Key Metrics
Latest Close
$5.33
Market Cap
$44M
Shares Outstanding
8,610,000
P/B Ratio
1.66
ROE
-3568.00%
ROA
-3336.00%
Gross Margin
6250.00%
Operating Margin
-741250.00%
Net Margin
-741250.00%
Debt / Equity
0
Current Ratio
14.99
Want the full picture?
Sign up free for full analysis, strategy backtesting with credibility scoring, portfolio management, and more.
Start Free